ArticleClinics and practice2024

A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment.

Hiroshi Ureshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.